SCA
BMY icon

Strategic Capital Alternatives’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Capital Alternatives’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,546
Closed -$102K – 324
2015
Q2 		$102K Hold
1,546
– – 0.02% 241
2015
Q1 		$100K Buy
+1,546
New +$96.8K 0.02% 206
2014
Q4 		– Sell
-1,163
Closed -$60K – 131
2014
Q3 		$60K Buy
+1,163
New +$58.1K 0.02% 214

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Strategic Capital Alternatives's BMY Position: Q3 2015 in Review

Strategic Capital Alternatives sold out of Bristol-Myers Squibb (BMY) in Q3 2015, closing a stake of 1,546 shares — an estimated $102K sold.

Strategic Capital Alternatives first reported a position in BMY in Q3 2014 and held it in 3 quarters. The position peaked at $102K in Q2 2015. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

  • Strategic Capital Alternatives reported no remaining Bristol-Myers Squibb position as of Q3 2015 after selling out during the quarter.
  • Strategic Capital Alternatives sold 1,546 Bristol-Myers Squibb shares in Q3 2015, an estimated $102K.
  • Strategic Capital Alternatives first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 3 quarters.
  • Strategic Capital Alternatives's Bristol-Myers Squibb position peaked at $102K in Q2 2015.
  • 1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.